How should rheology, G-prime and cohesivity claims for dermal fillers be read?

G-prime, viscosity, elasticity and cohesivity describe different aspects of laboratory behavior; one high or low value does not make a filler better, more natural or safer. The test method, temperature, frequency and intended clinical target need to be disclosed.

This translation has no recorded clinical or medical-language review.

Direct answer

The same named measure may not be comparable across instruments and test conditions.
A material property gains clinical meaning only with anatomy, plane, volume and product labeling.
Rheology is not a safety score that removes vascular, infection or nodule risk.

The measures are not interchangeable

G-prime describes storage modulus and one aspect of elastic behavior; loss modulus describes a viscous component; complex viscosity reflects resistance to flow. Cohesivity addresses how a gel mass holds together, using several possible tests. Crosslinking, HA concentration and particle structure also matter. One number cannot summarize all properties or predict tissue behavior.

Ask about test conditions

Temperature, frequency, strain, measurement geometry, sample preparation and instrument change results. A manufacturer's comparison within its own portfolio may not share a scale with an independent laboratory or another method. A marketing graph without axes, units, uncertainty and lot count cannot support ranking. Laboratory data do not replace human clinical evidence.

Limits of clinical translation

A deep support area, mobile lip and thin superficial tissue may need different material behavior, but G-prime alone cannot select a product. Authorized area, depth, anatomy, motion, prior filler and target volume belong in the decision. Superiority requires direct comparative outcome and safety evidence; a theoretical property is not a personal result prediction.

Scope of this article

This content is not diagnosis, prescribing, personal risk assessment or a treatment plan. Sources may be limited to a particular product, device, task, indication or study group.

Sources and evidence limits

These links are editorial starting points used to examine the article's boundaries.

Dermal Fillers (Soft Tissue Fillers)
U.S. Food and Drug Administration (FDA) · 2023
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Guideline for the Management of Hyaluronic Acid Filler-Induced Vascular Occlusion
Gillian Murray, Cormac Convery, Lee Walker, Emma Davies; Complications in Medical Aesthetics Collaborative (CMAC) · 2021
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Safety and Potential Complications of Facial Wrinkle Correction with Dermal Fillers: A Systematic Literature Review
Audra Janovskiene, Deividas Chomicius, Dominykas Afanasjevas, Zygimantas Petronis, Dainius Razukevicius, Egle Jagelaviciene · 2024
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
The Rheology and Physicochemical Characteristics of Hyaluronic Acid Fillers: Their Clinical Implications
Review authors · 2022
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Adverse Events Associated with Hyaluronic Acid Filler Injection: A Systematic Review of High-Level Evidence Studies
I. Kyriazidis et al. · 2024
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review